Related Experiment Video
Updated: Sep 12, 2025

Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
Retinal Neurovascular Signatures in Parkinson's Disease
Wenwen Zhu1,2, Andrew Hoover1,3, Lei Wan1,4
1Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, United States.
Purpose:
This study aimed to investigate retinal neurovascular signatures in patients with Parkinson's disease (PD) using multimodal neurovascular imaging.
Methods:
Fifteen patients with clinically diagnosed PD and eighteen age-matched healthy controls (HC) controls were recruited. Retinal blood flow (RBF) was measured using a retinal function imager. Retinal vessel density (RVD), retinal vessel length density (RVLD), and corresponding retinal tissue volume (RTV) were assessed using optical coherence tomography angiography. Retinal tissue perfusion (RTP) was computed as RBF normalized by RTV and retinal capillary function (RCF) as RBF normalized by RVLD.
Results:
Patients with PD exhibited significantly lower RBF, RTP, and RCF than HC (P < 0.001). RVD, RVLD, and RTV showed no significant difference between groups (P > 0.05). Additionally, the retinovascular variables RBF, RVD, RVLD, and RTV did not share a linear relationship with one another (P > 0.05).
Conclusions:
To the best of our knowledge, this study is the first to investigate retinal neurovascular signatures and provides novel insights into the interplay between retinal microstructure, microvasculature, and microcirculation in PD. Multimodal retinal imaging may offer a valuable window into the disease mechanism of PD.
More Related Videos
12:48In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma
Published on: May 11, 2015
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
Related Concept Videos
Neural Regulation
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...